PREVENTION

THE NEW PREVENTION ERA

Anna Dobbie investigates how longevity medicine, advanced diagnostic technology and personalised health strategies are shifting the sector’s focus toward preventative treatments

Not that long ago, a patient visiting an aesthetics clinic was most probably seeking treatment for visible signs of ageing. Today, many are asking a different question entirely: how can I stay healthier for longer?

From continuous glucose monitors and DNA testing to advanced blood analysis, wearable technology and artificial intelligence-powered health tracking, a new generation of preventative tools is changing the conversation around ageing. Patients are now looking beyond wrinkle reduction and skin rejuvenation towards a broader goal of optimising health, resilience, and longevity.

For aesthetic practitioners, this is both an opportunity and a challenge. As public interest in preventative health accelerates, clinics are positioning themselves somewhere between aesthetics, wellness and medicine. The modern patient is no longer focused solely on how they look, but on what their appearance may reveal about their root health.

“The future of prevention is not just more technology,” says Yasmin Shirazi, functional medicine practitioner and chief executive of Remedi London. “It is combining innovation together with human bonding, clinical wisdom and systems that make healthy choices easier.” Across aesthetic medicine, a new model of care is emerging. One that aims not simply to treat the visible effects of ageing but to identify and address the biological processes that drive them in the first place.

FROM ANTI-AGEING TO PREVENTION

The concept of anti-ageing has been part of aesthetic medicine since its conception, but the next phase of the sector’s evolution may be less about reversing age and more about preventing decline before it begins.

Experts describe a future in which health is continuously monitored rather than assessed only during occasional appointments. Genetic testing, metabolic analysis, immune profiling and wearable devices are expected to provide clinicians with an increasingly detailed picture of individual health risks long before symptoms develop.

Professor Tim Wang, founder of precision immunology company Cellimmune, which provides advanced next-generation sequencing blood testing, believes preventative medicine will become increasingly mainstream as clinicians gain access to more advanced methods for detecting what he describes as “sub-health” states.

“The treatment will be based on precision diagnosis of health status, not disease status,” he adds.

This approach is unlike traditional medicine, which typically intervenes after illness has already developed. Instead, practitioners are seeking ways to identify risk earlier and provide personalised interventions designed to preserve health rather than restore it.

Dr Ahmed El Muntasar, GP and owner of The Aesthetics Doctor, believes the future lies in identifying risk before symptoms appear.

“For me, next generation prevention is about shifting from reacting to disease to identifying risk much earlier and acting on it in a meaningful way,” he says.

The result is a rising emphasis on biomarkers, imaging, genetic risk profiles, and lifestyle data, which are combined to create a more complete picture of health.

THE SKIN NEVER LIES

Perhaps nowhere is the connection between health and appearance more visible than in aesthetic practice itself. While patients often present with concerns about skin quality, ageing or fatigue, practitioners increasingly recognise these issues as potential reflections of deeper physiological processes.

Gudiya Patel, managing director of PHI Clinic, says aesthetic concerns can often be the external manifestation of long-standing health challenges.

“People tend to only come in when the signs are already visible,” she explains. “Their skin may reflect years of poor sleep, high stress, blood sugar imbalance and chronic cortisol exposure.”

Inflammation, metabolic dysfunction, hormonal imbalance, sleep disruption, and chronic stress can all influence how the skin ages. As a result, many practitioners are looking beyond cosmetic symptoms and exploring the biological factors that contribute to them.

The face, in many ways, can act as an early warning system. Changes in skin quality, pigmentation, healing capacity, and collagen production may provide important signs of a patient’s overall health. While aesthetic treatments remain valuable, practitioners increasingly recognise that long-term results often depend on addressing underlying health factors as well.

THE TECHNOLOGIES DRIVING PREVENTION

Technology is central to the prevention movement, but experts stress that its value lies in generating effective insights rather than generating more data.

Artificial intelligence (AI) is expected to play a particularly important role. According to Prof Wang, the future of the sector will depend on AI’s ability to analyse vast quantities of biological information and identify patterns that would otherwise be impossible to detect.

“AI and multi-omics fusion, which is the integration of different ‘omics’ data types like genomics, transcriptomics, proteomics, and metabolomics to create a holistic picture of biological systems, will be the core approach,” he adds.

Wearable technology is also becoming increasingly sophisticated. Devices can now monitor sleep quality, activity levels, heart rate variability, recovery patterns and, in some cases, glucose responses in real time.

Patel identifies continuous glucose monitoring as one of the most powerful tools currently available.

“When someone sees their own glucose spike after a meal they thought was healthy, it often leads to instant behaviour change,” she says.

Genomic testing, microbiome analysis and advanced biomarker screening are also becoming more widely available. Together, these technologies promise to move healthcare away from generic recommendations and towards genuinely personalised interventions. However, several experts caution against viewing technology as a solution in itself.

“The real shift will be in how we interpret that data and translate it into clear, personalised action plans,” adds Dr El Muntasar.

THE RISK OF CREATING THE ‘WORRIED WELL’

As preventative medicine becomes more sophisticated, another challenge is emerging: how much information is too much?

While early detection can undoubtedly save lives, experts warn that excessive testing carries risks of its own: Not every abnormal result requires treatment, not every risk marker predicts disease, and not every patient benefits from constant monitoring.

Patel believes there is a fine line between empowering patients and creating unnecessary anxiety: “Constant monitoring can create anxiety and turn healthy individuals into perpetual patients.”

Dr Paul Banwell agrees that prevention must remain focused on meaningful clinical outcomes rather than simply identifying more abnormalities.

“We also need to be cautious about where early detection becomes overdiagnosis,” he says. “The focus should always be on clinically meaningful outcomes rather than simply detecting more.”

This balance will become increasingly important as diagnostic technologies continue to improve. The challenge for clinicians will be distinguishing between findings that require intervention and those that do not.

CAN PREVENTION BE ACCESSIBLE?

A recurring concern among experts is whether personalised prevention risks becoming a privilege available only to those who can afford it.

Many of today’s advanced preventative tools remain concentrated within private healthcare settings. Genetic testing, comprehensive biomarker analysis, specialist consultations and wearable technologies often come with high costs.

“If personalised prevention becomes something only available to people who can afford private testing, wearables, supplements and specialist consultations, then it could widen the gap,” warns Shirazi.

Professor Wang suggests that health itself could become increasingly tied to wealth if preventative technologies fail to become more accessible. The solution, experts argue, is not to slow innovation but to ensure that effective preventive tools are eventually integrated into mainstream healthcare.

At the same time, population-level interventions such as smoking cessation, vaccination programmes, nutrition education and obesity prevention remain essential. Personalisation may improve precision, but public health measures will continue to deliver the greatest impact at scale.

WHY HUMAN BEHAVIOUR REMAINS THE FINAL FRONTIER

For all the excitement surrounding artificial intelligence, genomics and predictive diagnostics, experts agree on one crucial point: technology alone cannot change behaviour.

Even the most sophisticated risk assessment is meaningless if patients fail to act on the information they receive.

“Simply telling someone they are at risk is rarely enough,” says Dr El Muntasar.

Instead, sustainable change depends on support, education and ongoing engagement.

Shirazi believes patients are far more likely to make lasting changes when they feel understood rather than judged, while Patel argues that behaviour is often closely linked to stress, emotional regulation and identity rather than knowledge alone.

Meanwhile, Dr MediaSpa founder Dr Munir Somji believes the sector must avoid becoming distracted by optimisation trends at the expense of basic health principles.

“There is a lot of focus on quick fixes, but real health starts with the basics,” he adds.

Before advanced interventions are considered, he advocates prioritising sleep, nutrition, stress management and appropriate medical assessment.

His view reflects a broader message emerging from the prevention movement: innovation is valuable, but fundamentals still matter most.

THE FUTURE AESTHETIC CLINIC

As the boundaries between aesthetics, wellness and medicine continue to blur, the role of the aesthetic practitioner is evolving.

Tomorrow’s clinic may look very different from today’s. Alongside injectables and energy-based devices, practitioners will increasingly need to use metabolic assessments, health-tracking technologies, genetic insights, and preventive health strategies to support patients over the long term.

ANNA DOBBIE

Anna Dobbie is a freelance editorial consultant and former editor of Aesthetic Medicine magazine. She studied Biological Natural Sciences at the University of Cambridge, with a focus on comparative cognition and animal behaviour.